Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Eur Urol. 2021 Dec 1;81(3):243–250. doi: 10.1016/j.eururo.2021.10.036

Table 2 –

Annual prostate cancer incidence rates per 1000 in the Li-Fraumeni syndrome (LFS) and in the Surveillance, Epidemiology, and End Results (SEER) registry

Age (yr) Restricted LFS cohort a SEER
Rate per 1000 95% CI Rate per 1000 95% CI
0–49 3.9 0.48–14 0.050 0.049–0.050
50–59 40 4.8–144 2.03 2.02–2.04
60–74 90 11–326 7.10 7.08–7.13
0–74 10 3.8–23 1.07 1.07–1.07

CI = confidence interval.

Results are by post hoc age at risk and all ages combined.

a

LFS cohort restricted to men with no prostate cancer diagnosis at the time of their genetic test.